Correlation Between Neoleukin Therapeutics and Kiora Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Neoleukin Therapeutics and Kiora Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neoleukin Therapeutics and Kiora Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neoleukin Therapeutics and Kiora Pharmaceuticals, you can compare the effects of market volatilities on Neoleukin Therapeutics and Kiora Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neoleukin Therapeutics with a short position of Kiora Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neoleukin Therapeutics and Kiora Pharmaceuticals.
Diversification Opportunities for Neoleukin Therapeutics and Kiora Pharmaceuticals
0.09 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Neoleukin and Kiora is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Neoleukin Therapeutics and Kiora Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kiora Pharmaceuticals and Neoleukin Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neoleukin Therapeutics are associated (or correlated) with Kiora Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kiora Pharmaceuticals has no effect on the direction of Neoleukin Therapeutics i.e., Neoleukin Therapeutics and Kiora Pharmaceuticals go up and down completely randomly.
Pair Corralation between Neoleukin Therapeutics and Kiora Pharmaceuticals
Given the investment horizon of 90 days Neoleukin Therapeutics is expected to under-perform the Kiora Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Neoleukin Therapeutics is 1.18 times less risky than Kiora Pharmaceuticals. The stock trades about -0.07 of its potential returns per unit of risk. The Kiora Pharmaceuticals is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 729.00 in Kiora Pharmaceuticals on August 31, 2024 and sell it today you would lose (403.00) from holding Kiora Pharmaceuticals or give up 55.28% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 8.56% |
| Values | Daily Returns |
Neoleukin Therapeutics vs. Kiora Pharmaceuticals
Performance |
| Timeline |
| Neoleukin Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Kiora Pharmaceuticals |
Neoleukin Therapeutics and Kiora Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neoleukin Therapeutics and Kiora Pharmaceuticals
The main advantage of trading using opposite Neoleukin Therapeutics and Kiora Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neoleukin Therapeutics position performs unexpectedly, Kiora Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kiora Pharmaceuticals will offset losses from the drop in Kiora Pharmaceuticals' long position.| Neoleukin Therapeutics vs. CytomX Therapeutics | Neoleukin Therapeutics vs. Spero Therapeutics | Neoleukin Therapeutics vs. Instil Bio | Neoleukin Therapeutics vs. NextCure |
| Kiora Pharmaceuticals vs. Virax Biolabs Group | Kiora Pharmaceuticals vs. Revelation Biosciences | Kiora Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | Kiora Pharmaceuticals vs. Allarity Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |